Skip to main content
SpringerLink
Log in

Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Studies of tissue inhibitors of metalloproteinases (TIMPs) suggest that one of their main functions is to inhibit metalloproteinase (MMP) activity and thus prevent tumor invasion by preserving extracellular matrix (ECM) integrity. In the present study we examined the distribution of transcripts for TIMP-1, MMP-2 and MMP-9 in monkey hepatocellular carcinoma tissues. In situ hybridization demonstrated elevated levels of TIMP-1 transcripts in fibrous tissue septa, tumor inflammatory infiltrate, tumor blood vessels and in expanded portal areas. However, elevated transcripts for MMP-2 and MMP-9 were found only in tumor inflammatory infiltrate. In lung metastasis high levels of TIMP-1 transcripts were found in the stromal cells surrounding necrotic tumor nodules, in tumor blood vessels, and in mesothelial cells. MMP-9 transcripts were elevated at the periphery of the necrotic tumor nodules. These findings suggest that TIMP-1 and type IV collagenases/gelatinases can be independently regulated in vivo and that TIMP-1 may have functions in ECM remodeling which are unrelated to inhibition of MMP activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mareel MM, De Baetselier P and Van Roy FM, 1991, Cellular activities implicated in invasion and metastasis. In: Mechanisms of Invasion and Metastasis. Boca Raton, Ann Arbor: CRC Press, pp. 73–219.

    Google Scholar 

  2. Turpeenniemi-Hujanen T, Thorgeirsson UP, Hart IR, Grant SS and Liotta LA, 1985, Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J Natl Cancer Inst, 75, 99–103.

    Google Scholar 

  3. Ballin M, Gomez DE, Sinha CC and Thorgeirsson UP, 1988, Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem Biophys Res Commun, 154, 832–8.

    Google Scholar 

  4. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K and Tryggvason K, 1992, Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res, 52, 1336–41.

    Google Scholar 

  5. Van Der Stappen JWJ, Hendriks T and Wobbes T, 1990, Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer, 45, 1071–8.

    Google Scholar 

  6. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE and Turner DR, 1991, Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumors. Int J Cancer, 49, 666–72.

    Google Scholar 

  7. Kossakowska AE, Urbanski SJ and Edwards DR, 1991, Tissue inhibitor of metalloproteinases-1 (TIM P-1) RNA is expressed at elevated levels in malignant nonHodgkin's lymphomas. Blood, 77, 2475–81.

    Google Scholar 

  8. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ and Edwards DR, 1993, Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res, 5, 19–28.

    Google Scholar 

  9. Poulsom R, Hanby AM, Pignatelli M, et al. 1993, Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol, 46, 429–36.

    Google Scholar 

  10. Hicks NJ, Ward RV and Reynolds JJ, 1984, A fibrosarcoma model derived from mouse embryo cells: growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumor cell lines. Int J Cancer, 33, 835–44.

    Google Scholar 

  11. Khokha R, Waterhouse P, Yagel S, et al. 1989, Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science, 243, 947–50.

    Google Scholar 

  12. Clavel C, Polette M, Doco M, Binninger I and Birembaut P, 1992, Immunolocalization of matrixmetalloproteinases and their tissue inhibitor in human mammary pathology. Bull Cancer, 79, 261–70.

    Google Scholar 

  13. Polette M, Clavel C, Birembaut P and De Clerk YA, 1993, Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Path Res Pract, 189, 1052–7.

    Google Scholar 

  14. Nakatsukasa H, 1986, Type IV collagen-degrading enzyme activity in hepatocellular carcinoma. Acta Med Okayama, 40, 183–91.

    Google Scholar 

  15. Fukada Y, Imoto M, Koyama Y, et al. 1991, Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterologica Japonica, 26, 37–41.

    Google Scholar 

  16. Muzillo DA, Imoto M, Fukada Y, et al. 1993, Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver disease. J Gastroenterol Hepatol, 8, 437–41.

    Google Scholar 

  17. Adamson RH, Takayama S, Sugimura T and Thorgeirsson UP, 1994, Induction of hepatocellular carcinoma in non-human primates by the food mutagen 2-amino-3methylimidazo[4,5-f]quinoline. Envir Hlth Perspect, 102, 190–3.

    Google Scholar 

  18. Angerer LM and Angerer RC, 1992, In situ hybridization to cellular RNA with radiolabelled RNA probes. In: Wilkinson DG, ed. In Situ Hybridization: A Practical Approach. Oxford: IRL Press at Oxford University Press, pp. 15–32.

    Google Scholar 

  19. Mackay AR, Ballin M, Pelina MD, et al. 1992, Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Met, 12, 168–84.

    Google Scholar 

  20. Edwards DR, Murphy G, Reynolds JJ, et al. 1987, Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J, 6, 1899–904.

    Google Scholar 

  21. Overall CM, Wrana JL and Sodek J, 1989, Independent regulation of collagenase, 72-kDa progelatinase and metalloproteinase inhibitor expression in human fibro blasts by transforming growth factor-beta. J Biol Chem, 264, 1860–9.

    Google Scholar 

  22. Lotz M and Guerne P-A, 1991, Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem, 266, 2017–20.

    Google Scholar 

  23. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI and Welgus HG, 1991, Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases and tissue inhibitor of metalloproteinases. J Immunol, 146, 1286–93.

    Google Scholar 

  24. Visscher DW, Hoyhtya M, Ottosen SK, et al. 1994, Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer, 59, 339–44.

    Google Scholar 

  25. Okazaki I and Maruyama K, 1974, Collagenase activity in experimental hepatic fibrosis. Nature, 252, 49–50.

    Google Scholar 

  26. Montfort I, Perez-Tamayo R, Alvizouri AM and Tello E, 1990, Collagenase of hepatocytes and sinusoidal liver cells in the reversibility of experimental cirrhosis of the liver. Virchows Archiv B Cell Pathol, 59, 281–9.

    Google Scholar 

  27. Milani S, Herbst H, Schuppan D, et al. 1994, Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol, 144, 528–37.

    Google Scholar 

  28. Montfort I and Perez-Tamayo R, 1978, Collagenase in experimental carbon tetrachloride cirrhosis of the liver. Am J Pathol, 92, 411–20.

    Google Scholar 

  29. Emonard HP, Remacle AG, Noel AG, Grimaud J-A, Stetler-Stevenson WG and Foidart J-M, 1992, Tumor cell surface-associated binding site for the Mr 72,000 type IV collagenase. Cancer Res, 52, 5845–8.

    Google Scholar 

  30. Zucker S, Wieman JM, Lysik RM, et al. 1987, Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells. Cancer Res, 47, 1608–14.

    Google Scholar 

  31. Zucker S, Moll VM, Lysik RM, et al. 1990, Extraction of type-IV collagenase/gelatinase from plasma membranes of human cancer cells. Int J Cancer, 45, 1137–42.

    Google Scholar 

  32. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE and Harris TJR, 1985, Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid potentiating activity. Nature, 315, 764–7.

    Google Scholar 

  33. Bertaux B, Hornebeck W, Eisen AZ and Dubertret L, 1991, Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol, 97, 679–85.

    Google Scholar 

  34. Gauldie J, Richards C, Harnish D, Lansdorp P and Baumann H, 1987, Interferon-beta 2/B cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci, 84, 7251–5.

    Google Scholar 

  35. Kordula T, Guttgemann I, Rose-John S, et al. 1992, Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Upregulation by interleukin-6 and transforming growth factor-beta 1. FEBS Lett, 313, 143–7.

    Google Scholar 

  36. Takigawa M, Nishida Y, Suzuki F, Kishi J-I, Yamashita K and Hayakawa T, 1990, Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). Biochem Biophys Res Commun, 172, 1264–71.

    Google Scholar 

  37. Johnson MD, Kim H-RC, Chester L, Tsao-Wu G, Bouk N and Polverini PJ, 1994, Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol, 160, 194–202.

    Google Scholar 

  38. Saarialho-Kere UK, Chang ES, Welgus HG and Parks WC, 1992, Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest, 90, 1952–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tumor Biology and Carcinogenesis Section, Office of the Director, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland, USA

    Carol K. Lindsay & Unnur P. Thorgeirsson

Authors
  1. Carol K. Lindsay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Unnur P. Thorgeirsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lindsay, C.K., Thorgeirsson, U.P. Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas. Clin Exp Metast 13, 381–388 (1995). https://doi.org/10.1007/BF00121914

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00121914

Keywords

Search

Navigation